CAP report and lab value
- CAP previewed its 2025 Practice Leader Survey Report, scheduled for public release on April 20 with practice-level data. - Daily Excelsior argued laboratory medicine remains under-recognised despite driving diagnoses and influencing clinical care decisions. - Together these items suggest pathology leaders should present measurable lab metrics to make diagnostic value visible to administrators (x.com) (dailyexcelsior.com).
Laboratory medicine produces most of the data doctors use, but pathology leaders are still being pushed to prove that value in numbers. (cap.org) (dailyexcelsior.com) The College of American Pathologists says its 2025 Practice Leader Survey results are “coming soon,” after launching the survey on June 9, 2025 and asking one leader from each U.S. pathology practice to report financial, operational, and billing data by June 23. (cap.org 1) (cap.org 2) CAP says the survey is built to capture practice demographics, case volume, staffing, revenue sources, payer mix, molecular pathology services, and the effects of mergers, acquisitions, coverage, and payment rules. (cap.org 1) (cap.org 2) That matters because hospital executives usually see laboratories as a cost center, while the lab’s output sits inside nearly every clinical decision. CAP says laboratory testing informs 70% of medical decisions and accounts for about 94% of the data in a typical patient record. (cap.org) A separate essay published April 18, 2026 by Daily Excelsior argued that laboratory medicine remains “under-recognized and under-resourced” even though it influences 70% to 80% of medical judgments. The piece pointed to delays and errors in sample collection, testing, and report interpretation as direct risks to diagnosis. (dailyexcelsior.com) Laboratory medicine is the part of health care that turns blood, tissue, and other samples into evidence a clinician can act on. The field covers clinical biochemistry, hematology, microbiology, and immunology, and its work ranges from routine blood counts to cancer-related testing. (dailyexcelsior.com) (cap.org) The pressure to quantify that work is rising as pathology groups face payment and regulatory fights. CAP said in June 2025 that survey data would help its advocacy on physician payment, new technologies, and other policy issues in Washington, and later tied that push to Medicare payment debates and the shutdown of the Clinical Laboratory Improvement Advisory Committee. (cap.org 1) (cap.org 2) Daily Excelsior described a different problem in resource-limited settings: outdated equipment, weak standard procedures, delayed reporting, and shortages of trained staff and reagents, especially outside urban centers. Those gaps can leave rural patients with slower diagnoses and fewer reliable test options. (dailyexcelsior.com) CAP’s own patient materials frame the counterargument pathology leaders can take to administrators: pathologists set quality standards, oversee testing, interpret results, and help decide when additional testing is needed. The survey’s practice-level benchmarks give those claims a format that finance offices and policymakers already use. (cap.org) (cap.org) The next marker is CAP’s public release of the 2025 Practice Leader Survey results. If the report lands with concrete staffing, volume, reimbursement, and case-mix numbers, pathology leaders will have a new set of figures for arguing that the lab is not just overhead. (cap.org)